Increasing Prevalence of Cancer and Cardio Diseases Mainly Driving Demand for Radiopharmaceuticals Market to Exceed $10 billion by 2024 - Market Research Report (2018-2025) by Industry Experts, Inc.
Industry Experts, Inc. unveiled the new global market research report "Global Radiopharmaceuticals Market – Products and Applications". The report reveals that the North American market is the largest accounts for more than half of the global market in 2018 with an estimated US$3.1 billion. Asia-Pacific is projected the fastest growing region with market growing at a CAGR of about 14% during 2018-2025.
Rising prevalence of cancer and cardiovascular diseases are the main factors driving the Radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of Radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the Radiopharmaceuticals market.
SPECT Radioisotopes constitute the single largest product type in global radiopharmaceuticals market, demand for which is expected to reach US$2.7 billion in 2019 while Beta Emitters is projected the fastest growing Radiopharmaceuticals product type globally during the analysis period 2018-2025 with a CAGR of 13.7%. Overall market for Radiopharmaceuticals in 2019 is expected to touch US$6.1 billion.
The Radiopharmaceutical product types market analyzed in this report includes SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters and Others comprising Brachytherapy, Auger electron, Coster-Kronig electron etc. The report examines the applications of Radiopharmaceuticals including Oncology, Cardiology, Neurology, Endocrinology, and Others comprising Nephrology, Immunology and Orthopedics etc.
The report reviews, analyzes and projects the radiopharmaceuticals market for global and the regional markets including the North America, Europe, Asia-Pacific and Rest of World for the period 2016-2025 in terms of value in USD. The regional markets further analyzed for 14 independent countries across North America – the United States and Canada; Europe – Germany, United Kingdom, France, Italy and Sweden; Asia-Pacific – Japan, China, India, Australia and South Korea; and Rest of World – Mexico and Brazil.
This 380 page global Radiopharmaceuticals market report includes 235 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. This report includes the brief business profiles of 19 key global players and 41 major players across the North America – 17; Europe – 14; Asia-Pacific – 7; and Rest of World – 3. The report also provides the listing of the companies engaged in research and development, custom synthesis, manufacturing, processing, supplies and distribution of Radiopharmaceuticals, radiopharmaceutical generators and industry associations. The global list covers the addresses, contact numbers and the website addresses of 100 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details, please visit: http://industry-experts.com/verticals/healthcare-and-pharma/global-radiopharmaceuticals-market-products-and-applications
Rising prevalence of cancer and cardiovascular diseases are the main factors driving the Radiopharmaceuticals market. Technological advancement, elevated healthcare expenditure, prevalence of chronic ailments, increasing geriatric population, rising awareness of Radiopharmaceuticals applications in disease treatment, poor dietary habits, unhealthy lifestyle and increased awareness about the benefits of targeted alpha therapy are some of the other key factors fueling the Radiopharmaceuticals market.
SPECT Radioisotopes constitute the single largest product type in global radiopharmaceuticals market, demand for which is expected to reach US$2.7 billion in 2019 while Beta Emitters is projected the fastest growing Radiopharmaceuticals product type globally during the analysis period 2018-2025 with a CAGR of 13.7%. Overall market for Radiopharmaceuticals in 2019 is expected to touch US$6.1 billion.
The report reviews, analyzes and projects the radiopharmaceuticals market for global and the regional markets including the North America, Europe, Asia-Pacific and Rest of World for the period 2016-2025 in terms of value in USD. The regional markets further analyzed for 14 independent countries across North America – the United States and Canada; Europe – Germany, United Kingdom, France, Italy and Sweden; Asia-Pacific – Japan, China, India, Australia and South Korea; and Rest of World – Mexico and Brazil.
This 380 page global Radiopharmaceuticals market report includes 235 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. This report includes the brief business profiles of 19 key global players and 41 major players across the North America – 17; Europe – 14; Asia-Pacific – 7; and Rest of World – 3. The report also provides the listing of the companies engaged in research and development, custom synthesis, manufacturing, processing, supplies and distribution of Radiopharmaceuticals, radiopharmaceutical generators and industry associations. The global list covers the addresses, contact numbers and the website addresses of 100 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details, please visit: http://industry-experts.com/verticals/healthcare-and-pharma/global-radiopharmaceuticals-market-products-and-applications
Comments
Post a Comment